JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)
WKN A2PR31 | ISIN LU2053353749 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0637847533 | Lacuna Global Health Plus I | +13,76 % | +11,61 % | 0,98 |
|
| 2 | LU0247050130 | Lacuna Global Health Plus P | +13,63 % | +11,61 % | 0,97 |
|
| 3 | LU0695506492 | BZ Fine Funds - BZ Fine Pharma A EUR | +9,06 % | +15,07 % | 0,45 |
|
| 4 | BE0170812920 | KBC Equity Fund Medical Technologies Classic | +6,95 % | +11,29 % | 0,41 |
|
| 5 | LU2036817042 | CPR Invest - MedTech - A EUR - Dist | -0,09 % | +13,58 % | -0,18 |
|
| 108 | IE00BNGJLK89 | Premium Selection UCITS ICAV - Polar Capital Future Healthcare Ah dis CHF | -12,60 % | +13,37 % | -1,12 |
|
| 109 | LU2053353749 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | -22,13 % | +21,30 % | -1,15 |
|
| 110 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | -22,55 % | +21,31 % | -1,17 |
|
| 111 | LU2314628723 | JPMorgan Funds - Thematics - Genetic Therapies C (dist) - GBP | -22,43 % | +19,69 % | -1,26 |
|
| 112 | LU2015349090 | Candriam Equities L Oncology, S-AH - Distribution | -14,29 % | +12,01 % | -1,39 |
|